Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

Part of paid clinical trials in San Francisco, California.

Sponsor
Power Life Sciences Inc.
Study ID
NCT06254157
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Generalized Anxiety Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Typically, certain demographic groups tend to participate more in medical research. However, there is insufficient research explaining the trial characteristics that influence the involvement of these specific demographics. This study aims to collect extensive data on the clinical trial experiences of individuals with generalized anxiety disorder. The goal is to identify the factors that hinder a patient's enrollment or completion of a trial. Additionally, the research will examine the data from various demographic perspectives to identify recurring patterns that could offer valuable insights for future generalized anxiety disorder patients.

Key Dates

Start date
Mar 31, 2025
Status verified
Feb 2024
Primary completion
Mar 31, 2026
Completion
Mar 31, 2027

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Rate of patients who decide to enroll in a generalized anxiety disorder clinical research. [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Power Life SciencesSan FranciscoCalifornia94107
Michael B Gill
https://www.withpower.com/[email protected]
415-900-4227

Find similar trials in San Francisco, CA

By research site
Power Life Sciences· San Francisco, CA

Related Studies